pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-637 |
Genomic Coordinates | chr19: 3961414 - 3961512 |
Synonyms | MIRN637, hsa-mir-637, MIR637 |
Description | Homo sapiens miR-637 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-637 | |||||||||||||||||||||||||||||||||||||||
Sequence | 61| ACUGGGGGCUUUCGGGCUCUGCGU |84 | |||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | SAGE | |||||||||||||||||||||||||||||||||||||||
Expression Profile | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ACPP | ||||||||||||||||||||
Synonyms | 5'-NT, ACP-3, ACP3 | ||||||||||||||||||||
Description | acid phosphatase, prostate | ||||||||||||||||||||
Transcript | NM_001099 | ||||||||||||||||||||
Other Transcripts | NM_001134194 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ACPP | |||||||||||||||||||||
3'UTR of ACPP (miRNA target sites are highlighted) |
>ACPP|NM_001099|3'UTR 1 TGTGCACAGAGATCTCTGTAGAAGGAGTAGCTGCCCTTTCTCAGGGCAGATGATGCTTTGAGAACATACTTTGGCCATTA 81 CCCCCAGCTTTGAGGAAAATGGGCTTTGGATGATTATTTTATGTTTTAGGGACCCCCAACCTCAGGCAATTCCTACCTCT 161 TCACCTGACCCTGCCCCCACTTGCCATAAAACTTAGCTAAGTTTTGTTTTGTTTTTCAGCGTTAATGTAAAGGGGCAGCA 241 GTGCCAAAATATAATCAGAGATAAAGCTTAGGTCAAAGTTCATAGAGTTCCCATGAACTATATGACTGGCCACACAGGAT 321 CTTTTGTATTTAAGGATTCTGAGATTTTGCTTGAGCAGGATTAGATAAGGCTGTTCTTTAAATGTCTGAAATGGAACAGA 401 TTTCAAAAAAAAACCCCACAATCTAGGATGGGAACAAGGAAGGAAAGATGTGAATAGGCTGATGGGCAAAAAACCAATTT 481 ACCCATCAGTTCCAGCCTTCTCTCAAGGAGAGGCAAAGAAAGGAGATACAGTGGAGACATCTGGAAAGTTTTCTCCACTG 561 GAAAACTGCTACTATCTGTTTTTATATTTCTGTTAAAATATATGAGGCTACAGAACTAAAAATTAAAACCTCTTTGTGTC 641 CCTTGGTCCTGGAACATTTATGTTCCTTTTAAAGAAACAAAAATCAAACTTTACAGAAAGATTTGATGTATGTAATACAT 721 ATAGCAGCTCTTGAAGTATATATATCATAGCAAATAAGTCATCTGATGAGAACAAGCTATTTGGGCACAACACATCAGGA 801 AAGAGAGCACCACGTGATGGAGTTTCTCTAGAAGCTCCAGTGATAAGAGATGTTGACTCTAAAGTTGATTTAAGGCCAGG 881 CATGGTGGTTTACGCCTATAATCCCAGCATTTTGGGAGTCCGAGGTGGGCAGATCACTTGAGCTCAGGAGGTCAAGATCA 961 GCCTGGGCAACATGGTGAAACCTGGTCTCTACATAAAATACAAAAACTTAGATGGGCATGGTGGTGTGTGCCTATAGTCC 1041 CACTACTTGTGGGGCTAAGGCAGGAGGATCACTTGAGCCCCGGAGGTCGAGGCTACAGTGAGCCAAGAGTGCACTACTGT 1121 ACTCCAGCCAGGGCAAGAGAGCGAGACCCTGTCTCAATAAATAAATAAATAAATAAATAAATAAATAAATAAATAAATAA 1201 AAACAAAGTTGATTAAGAAAGGAAGTATAGGCCAGGCACAGTGGCTCACACCTGTAATCCTTGCATTTTGGAAGGCTGAG 1281 GCAGGAGGATCACTTTAGGCCTGGTGTGTTCAAGACCAGCCTGGTCAACATAGTGAGACACTGTCTCTACCAAAAAAAGG 1361 AAGGAAGGGACACATATCAAACTGAAACAAAATTAGAAATGTAATTATGTTCTAAGTGCCTCCAAGTTCAAAACTTATTG 1441 GAATGTTGAGAGTGTGGTTACGAAATACGTTAGGAGGACAAAAGGAATGTGTAAGTCTTTAATGCCGATATCTTCAGAAA 1521 ACCTAAGCAAACTTACAGGTCCTGCTGAAACTGCCCACTCTGCAAGAAGAAATCATGATATAGCTTTGCCATGTGGCAGA 1601 TCTACATGTCTAGAGAACACTGTGCTCTATTACCATTATGGATAAAGATGAGATGGTTTCTAGAGATGGTTTCTACTGGC 1681 TGCCAGAATCTAGAGCAAAGCCATCCCCGCTCCTGGTTGGTCACAGAATGACTGACAAAGACATCGATTGATATGCTTCT 1761 TTGTGTTATTTCCCTCCCAAGTAAATGTTTGTCCTTGGGTCCATTTTCTATGCTTGTAACTGTCTTCTAGCAGTGAGCCA 1841 AATGTAAAATAGTGAATAAAGTCATTATTAGGAAGTTCAAAAGCATTGCTTTTATAATGAACTTAGAAAAACGTATGTGT 1921 GTGTGTTTAATTAGAATAAAATTCCTCTAGGCAGATTTCAGGAGCTCCAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000336375.5 | 3UTR | UUGGCCAUUACCCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
69 hsa-miR-637 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006147 | SP7 | Sp7 transcription factor | 3 | 1 | ||||||||
MIRT054906 | COL4A1 | collagen type IV alpha 1 chain | 1 | 1 | ||||||||
MIRT159142 | NRBP1 | nuclear receptor binding protein 1 | 2 | 2 | ||||||||
MIRT358526 | HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 2 | 2 | ||||||||
MIRT441490 | NCEH1 | neutral cholesterol ester hydrolase 1 | 2 | 2 | ||||||||
MIRT443472 | ACPP | acid phosphatase, prostate | 2 | 2 | ||||||||
MIRT464631 | UBE4A | ubiquitination factor E4A | 2 | 2 | ||||||||
MIRT465259 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT473975 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT475168 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT477631 | EFNA1 | ephrin A1 | 2 | 2 | ||||||||
MIRT480100 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT483504 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT483735 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT483847 | UNC5B | unc-5 netrin receptor B | 2 | 2 | ||||||||
MIRT485973 | RTBDN | retbindin | 2 | 2 | ||||||||
MIRT486616 | METTL6 | methyltransferase like 6 | 2 | 2 | ||||||||
MIRT487847 | CLSTN1 | calsyntenin 1 | 2 | 4 | ||||||||
MIRT488675 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 2 | 4 | ||||||||
MIRT489046 | PRPF4B | pre-mRNA processing factor 4B | 2 | 2 | ||||||||
MIRT490612 | SLC47A1 | solute carrier family 47 member 1 | 2 | 4 | ||||||||
MIRT490990 | USP22 | ubiquitin specific peptidase 22 | 2 | 2 | ||||||||
MIRT492559 | PRX | periaxin | 2 | 2 | ||||||||
MIRT494667 | ARL8A | ADP ribosylation factor like GTPase 8A | 2 | 2 | ||||||||
MIRT495880 | DPY19L1 | dpy-19 like C-mannosyltransferase 1 | 2 | 2 | ||||||||
MIRT496778 | ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif 14 | 2 | 2 | ||||||||
MIRT499742 | USH1G | USH1 protein network component sans | 2 | 4 | ||||||||
MIRT500371 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT503257 | KIF18B | kinesin family member 18B | 2 | 2 | ||||||||
MIRT504511 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | 2 | 2 | ||||||||
MIRT511940 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT514606 | NDUFA12 | NADH:ubiquinone oxidoreductase subunit A12 | 2 | 4 | ||||||||
MIRT527187 | CLASP1 | cytoplasmic linker associated protein 1 | 2 | 2 | ||||||||
MIRT532494 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT533504 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT539171 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT542735 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 2 | ||||||||
MIRT544647 | PHF8 | PHD finger protein 8 | 2 | 4 | ||||||||
MIRT546232 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | 2 | 2 | ||||||||
MIRT548372 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 4 | ||||||||
MIRT555913 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 2 | 2 | ||||||||
MIRT565381 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT568954 | RUNX3 | runt related transcription factor 3 | 2 | 2 | ||||||||
MIRT570205 | RAP1GAP2 | RAP1 GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT573599 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT615364 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT616102 | HOXB5 | homeobox B5 | 2 | 2 | ||||||||
MIRT619127 | CD40LG | CD40 ligand | 2 | 2 | ||||||||
MIRT634968 | C8orf17 | chromosome 8 open reading frame 17 | 2 | 2 | ||||||||
MIRT646665 | FNBP1 | formin binding protein 1 | 2 | 2 | ||||||||
MIRT649633 | RASA4 | RAS p21 protein activator 4 | 2 | 2 | ||||||||
MIRT658443 | FAM167B | family with sequence similarity 167 member B | 2 | 2 | ||||||||
MIRT660237 | BMP7 | bone morphogenetic protein 7 | 2 | 2 | ||||||||
MIRT669467 | ATL3 | atlastin GTPase 3 | 2 | 2 | ||||||||
MIRT670557 | SHISA2 | shisa family member 2 | 2 | 2 | ||||||||
MIRT671035 | PCDHB2 | protocadherin beta 2 | 2 | 2 | ||||||||
MIRT684255 | TBXA2R | thromboxane A2 receptor | 2 | 2 | ||||||||
MIRT688619 | CYBRD1 | cytochrome b reductase 1 | 3 | 2 | ||||||||
MIRT694346 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT695516 | ALPI | alkaline phosphatase, intestinal | 2 | 2 | ||||||||
MIRT697512 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT700133 | RNF144B | ring finger protein 144B | 2 | 2 | ||||||||
MIRT711667 | TRMT5 | tRNA methyltransferase 5 | 2 | 2 | ||||||||
MIRT712156 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT712463 | KCNC3 | potassium voltage-gated channel subfamily C member 3 | 2 | 2 | ||||||||
MIRT720759 | FAM193A | family with sequence similarity 193 member A | 2 | 2 | ||||||||
MIRT731198 | AKT1 | AKT serine/threonine kinase 1 | 2 | 1 | ||||||||
MIRT755463 | PACS2 | phosphofurin acidic cluster sorting protein 2 | 1 | 1 | ||||||||
MIRT755522 | FOXM1 | forkhead box M1 | 3 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|